1 Introduction Polycystic ovary syndrome (PCOS) represents one of the most complex endocrine-metabolic disorders affecting women of reproductive age, characterized by a collection of reproductive, metabolic, and psychological manifestations ( Beyond the classic triad of hyperandrogenism (HA), ovulatory dysfunction, and polycystic ovarian morphology, PCOS extends into domains of insulin resistance, dyslipidemia, chronic inflammation, and heightened oxidative stress (OS) ( Conventional therapeutic strategies, though effective in symptom control, remain largely palliative, targeting isolated components of this multifactorial syndrome ( Thus, this review critically examines the triadic potential of these agents, not as standalone supplements but as a synergistic bioactive cocktail targeting the redox-endocrine axis
Peeters TL, Muls E, Janssens J, Urbain JL, Bex M, Van Cutsem E, et al
This is often preferred for weight loss and general health because it avoids the potential contaminants associated with wood-smoke drying
During the 24-week period after the PRP, Dr
In immortalised human airway epithelial cell lines (including bronchial epithelial cells) and human alveolar epitheliallike cells, GLP-1 receptor agonists reduced epithelial stress and inflammatory signalling, including downregulation of epithelial-derived cytokines, including IL-33 and thymic stromal lymphopoietin (TSLP), both of which are implicated in epithelialmesenchymal crosstalk and fibroblast recruitment in fibrotic lung disease [66,67,68]
It often means the dose needs to be re-evaluated